Mega Lifesciences Correlations
MEGA Stock | THB 30.50 0.25 0.83% |
The current 90-days correlation between Mega Lifesciences Public and Com7 PCL is 0.2 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mega Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mega Lifesciences Public moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Mega Lifesciences Correlation With Market
Significant diversification
The correlation between Mega Lifesciences Public and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mega Lifesciences Public and DJI in the same portfolio, assuming nothing else is changed.
Mega |
The ability to find closely correlated positions to Mega Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mega Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mega Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mega Lifesciences Public to buy it.
Moving together with Mega Stock
0.85 | JTS | Jasmine Telecom Systems | PairCorr |
0.81 | DITTO | Ditto Public | PairCorr |
0.8 | BEM-R | Bangkok Expressway and | PairCorr |
0.72 | DITTO-R | DITTO | PairCorr |
0.75 | SPA | Siam Wellness Group | PairCorr |
0.79 | DELTA | Delta Electronics Public | PairCorr |
0.86 | FORTH | Forth Public | PairCorr |
Moving against Mega Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Mega Stock performing well and Mega Lifesciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mega Lifesciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
HMPRO | 1.86 | (0.18) | 0.00 | (0.13) | 0.00 | 4.00 | 9.65 | |||
MINT | 1.30 | 0.09 | 0.05 | 0.20 | 1.33 | 2.78 | 8.38 | |||
COM7 | 1.68 | (0.35) | 0.00 | 3.14 | 0.00 | 3.48 | 10.27 | |||
BDMS | 1.17 | (0.19) | 0.00 | (0.46) | 0.00 | 2.97 | 7.36 | |||
BCH | 1.48 | (0.19) | 0.00 | (0.38) | 0.00 | 4.14 | 8.79 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Mega Lifesciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
All Next | Launch Module |
Mega Lifesciences Corporate Management
Elected by the shareholders, the Mega Lifesciences' board of directors comprises two types of representatives: Mega Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mega. The board's role is to monitor Mega Lifesciences' management team and ensure that shareholders' interests are well served. Mega Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mega Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Duangnapa Tongsiri | Pres Thailand | Profile | |
Apichai Chanjarusiri | Manufacturing Thailand | Profile | |
Manoj Gurbuxani | Deputy Officer | Profile | |
Deepak Panjwani | Chief Officer | Profile |